ETR:LXS LANXESS Aktiengesellschaft (LXS) Stock Price, News & Analysis €28.48 -0.14 (-0.49%) As of 02/20/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About LANXESS Aktiengesellschaft Stock (ETR:LXS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LXS alerts:Sign Up Key Stats Today's Range€27.80▼€29.1250-Day Range€22.47▼€30.3152-Week Range€20.14▼€29.80Volume333,164 shsAverage Volume312,027 shsMarket Capitalization$2.58 billionP/E RatioN/ADividend Yield0.35%Price TargetN/AConsensus RatingN/A Company OverviewLANXESS Aktiengesellschaft, together with its subsidiaries, operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. The Specialty Additives segment offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for a variety of applications in for the rubber, plastic and paint, electrical/electronics, and construction industries. The Advanced Intermediates segment provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials as well as paints and coatings. The segment serves agrochemical, automotive, construction, aromas and flavors, semiconductors and photovoltaic, and color pigments industries. LANXESS Aktiengesellschaft was founded in 1863 and is headquartered in Cologne, Germany.Read More… Receive LXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LANXESS Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address LXS Stock News HeadlinesLanxess AG: LANXESS neu bewerten nach einer erfolgreichen Portfolio-Transformation; mwb research bestätigt KAUFENFebruary 21 at 5:13 PM | finanznachrichten.deLanxess downgraded to Hold from Buy at Kepler CheuvreuxFebruary 20 at 7:28 AM | markets.businessinsider.comWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.February 21, 2025 | Behind the Markets (Ad)Lanxess-Aktie auf "Halten" hochgestuft, Kursziel auf 30 EUR angehobenFebruary 18 at 7:23 PM | de.investing.comEQS-DD: LANXESS Aktiengesellschaft: Frederique van Baarle, buyFebruary 17, 2025 | markets.businessinsider.comJPMORGAN stuft LANXESS AG auf 'Underweight'JPMORGAN stuft LANXESS AG auf 'Underweight'February 7, 2025 | finanznachrichten.deJPMORGAN stuft LANXESS AG auf 'Underweight'February 6, 2025 | finanznachrichten.deIs LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 50% Discount?January 31, 2025 | finance.yahoo.comSee More Headlines LXS Stock Analysis - Frequently Asked Questions How have LXS shares performed this year? LANXESS Aktiengesellschaft's stock was trading at €23.58 at the beginning of the year. Since then, LXS shares have increased by 20.8% and is now trading at €28.48. View the best growth stocks for 2025 here. What other stocks do shareholders of LANXESS Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some other companies that LANXESS Aktiengesellschaft investors own include Bayer Aktiengesellschaft (BAYN), Siemens Aktiengesellschaft (SIE), Heidelberg Materials (HEI), Covestro (1COV), AbbVie (ABBV), Broadcom (AVGO) and Alibaba Group (BABA). Industry, Sector and Symbol Stock ExchangeETR SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolETR:LXS CUSIPN/A CIKN/A Weblanxess.de Phone+49-221-88850FaxN/AEmployees12,621Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)(€9.56) Trailing P/E RatioN/A Forward P/E Ratio14.41 P/E Growth1.12Net Income$-908,199,759.60 Net Margins-13.70% Pretax MarginN/A Return on Equity-19.26% Return on Assets-0.47% Debt Debt-to-Equity RatioN/A Current Ratio1.96 Quick Ratio0.57 Sales & Book Value Annual Sales$6.63 billion Price / Sales0.39 Cash Flow€4.79 per share Price / Cash Flow5.95 Book Value€50.70 per share Price / Book0.56Miscellaneous Outstanding Shares90,553,916Free FloatN/AMarket Cap$2.58 billion OptionableNot Optionable Beta1.62 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ETR:LXS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LANXESS Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share LANXESS Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.